PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER

Introduction. Stomach cancer remains one of the most common malignancies with an unfavorable prognosis. It is the 5-th most frequent cancer and the 3rd leading cause of cancer death worldwide and in Russia as well. Combined modality treatment including radical surgery and perioperative / adjuvant th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	V. Yu. Skoropad, S. G. Afanasyev, S. V. Gamayunov, N. K. Silanteva, T. A. Agababyan, P. V. Sokolov, S. A. Ivanov, A. D. Kaprin
Formato:	Artigo
Idioma:	Russo
Publicado em:	Russian Academy of Sciences, Tomsk National Research Medical Center 2020-03-01
coleção:	Сибирский онкологический журнал
Assuntos:	gastric cancer neoadjuvant chemo-radiotherapy d2 gastrectomy adjuvant chemotherapy multicenter randomized trial
Acesso em linha:	https://www.siboncoj.ru/jour/article/view/1316
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!